BioGaia

Regulatory Filings • Sep 18, 2009

Press Release 18 September 2009

BioGaia signs agreement for France

BioGaia has signed a distribution agreement with the French company Laboratoires BIOETHIC. The agreement gives Laboratoires BIOETHIC exclusive rights to sell BioGaia´s Probiotic drops and tablets in France. The products will be sold under the BioGaia brand.

Laboratoires BIOETHIC specialises in sales and marketing of pharmaceutical products in France.

"Given BioGaia´s extensive clinical studies in the area and the large sales force that will work with BioGaia´s products on the French market, we at Laboratoires BIOETHIC have high expectations for this collaboration." says Frédéric Derome, Managing Director, Laboratoires BIOETHIC.

The launch of BioGaia´s Probiotic drops, containing Lactobacillus reuteri, in France is planned in Autumn 2009, whilst tablet sales will start Spring 2010.

"We are happy to have contracted a distributor in France who work according to our now well-established model with the BioGaia brand, especially since we consider that France can become an important market for us." says Peter Rothschild, Managing Director, BioGaia.

Latest press releases from BioGaia:

2009-09-17 Personnel changes at BioGaia 2009-08-18 BioGaia AB Interim report 1 January – 30 June 2009 2009-06-30 BioGaia signs new agreement with Semper for unique probiotic Oral Rehydration Solution (ORS)

For additional information contact:

Peter Rothschild, Managing Director, telephone: +46 8 -555 293 00 Jan Annwall, Deputy Managing Director, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com